MedPath

study of Covid 19 infection in hemodialysis and post renal transplant patients

Not Applicable
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: N186- End stage renal diseaseHealth Condition 3: Z940- Kidney transplant status
Registration Number
CTRI/2020/12/029478
Lead Sponsor
DrMaulin Shah
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All covid positive (Rapid antigen test or RT PCR) end stage renal disease and renal transplant patients admitted in shree Krishna hospital for further management

All covid positive end stage renal disease and renal transplant patients who visited flu opd and advised for home quarantine and dialysis in covid ICU on day car basis

Exclusion Criteria

Those Covid positive end stage renal disease patients will be excluded from study whose complete data not available in hospital record

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
This study will give us robust data regarding impact of covid 19 on survival of end stage renal disease and post renal transplant patientsTimepoint: 4 months
Secondary Outcome Measures
NameTimeMethod
efficacy of various treatment modality against covid 19 in hemodialysis and postrenal transplant patientsTimepoint: 2 months
© Copyright 2025. All Rights Reserved by MedPath